Paper41597255
The Regulatory Role of m6A Modification in the Function and Signaling Pathways of Animal Stem Cells.
Yang X and 5 others. Cells, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The Regulatory Role of m6A Modification in the Function and Signaling Pathways of Animal Stem Cells. Papers, record 41597255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41597255
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Regulatory Role of m6A Modification in the Function and Signaling Pathways of Animal Stem Cells.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Signal Transduction | Major topic |
| Adenosine | Major topic |
| Stem Cells | Major topic |
| Animals | |
| RNA Methylation | |
| Humans | |
| Cellular Reprogramming | |
| Epitranscriptome | |
| Epigenesis, Genetic | |
| Cell Differentiation |
Source PubMed
References162
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35385105 | Downregulation of Odd-Skipped Related 2, a Novel Regulator of Epithelial-Mesenchymal Transition, Enables Efficient Somatic Cell Reprogramming. | Stem Cells | 2022 | https://conductscience.org/library/papers/35385105 | PubMed |
| 2 | 37957340 | Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma. | Nat Genet | 2023 | https://conductscience.org/library/papers/37957340 | PubMed |
| 3 | 33442060 | m6A RNA methylation regulates the fate of endogenous retroviruses. | Nature | 2021 | https://conductscience.org/library/papers/33442060 | PubMed |
| 4 | 28809393 | Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis. | Cell Res | 2017 | https://conductscience.org/library/papers/28809393 | PubMed |
| 5 | 38566168 | Profiling the role of m6A effectors in the regulation of pluripotent reprogramming. | Hum Genomics | 2024 | https://conductscience.org/library/papers/38566168 | PubMed |
| 6 | 29359466 | Wnt/β-Catenin/TCF Pathway Is a Phase-Dependent Promoter of Colony Formation and Mesendodermal Differentiation During Human Somatic Cell Reprogramming. | Stem Cells | 2018 | https://conductscience.org/library/papers/29359466 | PubMed |
| 7 | 35033632 | RNA m6A methylation regulates dissemination of cancer cells by modulating expression and membrane localization of β-catenin. | Mol Ther | 2022 | https://conductscience.org/library/papers/35033632 | PubMed |
| 8 | 33886094 | Nuclear m6A reader YTHDC1 regulates the scaffold function of LINE1 RNA in mouse ESCs and early embryos. | Protein Cell | 2021 | https://conductscience.org/library/papers/33886094 | PubMed |
| 9 | 32359707 | Metabolic Regulation of Tissue Stem Cells. | Trends Cell Biol | 2020 | https://conductscience.org/library/papers/32359707 | PubMed |
| 10 | 37056926 | M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37056926 | PubMed |
| 11 | 32183948 | m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. | Cancer Cell | 2020 | https://conductscience.org/library/papers/32183948 | PubMed |
| 12 | 36566000 | ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation. | Pharmacol Res | 2023 | https://conductscience.org/library/papers/36566000 | PubMed |
| 13 | 29529255 | N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/29529255 | PubMed |
| 14 | 24554433 | Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition. | J Cell Sci | 2014 | https://conductscience.org/library/papers/24554433 | PubMed |
| 15 | 24656769 | Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency. | Cell Stem Cell | 2014 | https://conductscience.org/library/papers/24656769 | PubMed |
| 16 | 38293837 | METTL3-mediated m6A modification of EPPK1 to promote the development of esophageal cancer through regulating the PI3K/AKT pathway. | Environ Toxicol | 2024 | https://conductscience.org/library/papers/38293837 | PubMed |
| 17 | 33800464 | YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming. | Metabolites | 2021 | https://conductscience.org/library/papers/33800464 | PubMed |
| 18 | 30787270 | m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/30787270 | PubMed |
| 19 | 32106857 | m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC. | Mol Cancer | 2020 | https://conductscience.org/library/papers/32106857 | PubMed |
| 20 | 37640841 | RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation. | Nat Cell Biol | 2023 | https://conductscience.org/library/papers/37640841 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42929819 | Timeline of Achieving a Differentiated RPE Phenotype and Specialised Metabolism of ARPE-19 Cells Under Physiologically Relevant-Inducing Culture Conditions. | Cells | 2026 | https://conductscience.org/library/papers/42929819 | PubMed |
| 42262586 | The relevance of m6A RNA modifications in cancer stem cells. | J Cancer Res Clin Oncol | 2026 | https://conductscience.org/library/papers/42262586 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| PIK3CB | 5291 | PubTator's text mining | https://conductscience.org/library/genes/5291 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41597255
GET https://conductscience.org/api/papers/v1/41597255/references?page=2